BRIDION, known generically as sugammadex, is a medication primarily used in the field of anesthesia. It functions as a selective relaxant binding agent, specifically designed to reverse the effects of certain muscle relaxants used during surgical procedures, namely rocuronium and vecuronium. By encapsulating the muscle relaxant molecules and rendering them inactive, BRIDION effectively and rapidly restores neuromuscular function, allowing patients to recover from paralysis more quickly after surgery. This innovative approach to reversing anesthesia-induced muscle relaxation has made BRIDION an important tool in improving postoperative recovery and safety. Its use is typically reserved for hospital or surgical settings and administered by healthcare professionals trained in its application.